Published in J Cell Mol Med on December 04, 2012
Autophagy in the eye: implications for ocular cell health. Exp Eye Res (2014) 1.00
Morphological Features of Organelles during Apoptosis: An Overview. Cells (2013) 0.86
TNF-α mediates PKCδ/JNK1/2/c-Jun-dependent monocyte adhesion via ICAM-1 induction in human retinal pigment epithelial cells. PLoS One (2015) 0.82
Autophagy and mitochondrial alterations in human retinal pigment epithelial cells induced by ethanol: implications of 4-hydroxy-nonenal. Cell Death Dis (2014) 0.80
Molecular features of the cytotoxicity of an NHE inhibitor: Evidence of mitochondrial alterations, ROS overproduction and DNA damage. BMC Cancer (2016) 0.75
AIF-independent parthanatos in the pathogenesis of dry age-related macular degeneration. Cell Death Dis (2017) 0.75
The retinal pigment epithelium in visual function. Physiol Rev (2005) 8.59
ARPE-19, a human retinal pigment epithelial cell line with differentiated properties. Exp Eye Res (1996) 5.97
Autophagy: assays and artifacts. J Pathol (2010) 3.45
Disruption of autophagy at the maturation step by the carcinogen lindane is associated with the sustained mitogen-activated protein kinase/extracellular signal-regulated kinase activity. Cancer Res (2006) 2.87
Poly(ADP-ribose) signals to mitochondrial AIF: a key event in parthanatos. Exp Neurol (2009) 2.24
Transplantation of the RPE in AMD. Prog Retin Eye Res (2007) 1.81
Age-related retinopathy in NRF2-deficient mice. PLoS One (2011) 1.71
PARP-1 is involved in autophagy induced by DNA damage. Autophagy (2009) 1.50
Inhibition of the ATP-driven proton pump in RPE lysosomes by the major lipofuscin fluorophore A2-E may contribute to the pathogenesis of age-related macular degeneration. FASEB J (2004) 1.48
Conversation between apoptosis and autophagy: "Is it your turn or mine?". Apoptosis (2011) 1.24
PARP inhibition sensitizes p53-deficient breast cancer cells to doxorubicin-induced apoptosis. Biochem J (2005) 1.19
Age-related macular degeneration. Adv Exp Med Biol (2012) 1.12
CO2-induced ion and fluid transport in human retinal pigment epithelium. J Gen Physiol (2009) 1.11
Chloroquine treatment of ARPE-19 cells leads to lysosome dilation and intracellular lipid accumulation: possible implications of lysosomal dysfunction in macular degeneration. Cell Biosci (2011) 1.02
Cytosolic acidification and lysosomal alkalinization during TNF-alpha induced apoptosis in U937 cells. Apoptosis (2006) 1.01
ARPE-19 retinal pigment epithelial cells are highly resistant to oxidative stress and exercise strict control over their lysosomal redox-active iron. Autophagy (2009) 0.96
Apoptosis induced by Na+/H+ antiport inhibition activates the LEI/L-DNase II pathway. Cell Death Differ (2003) 0.92
Regulation of poly(ADP-ribose) polymerase-1 functions by leukocyte elastase inhibitor/LEI-derived DNase II during caspase-independent apoptosis. Int J Biochem Cell Biol (2008) 0.84
Molecular mechanism of L-DNase II activation and function as a molecular switch in apoptosis. Biochem Pharmacol (2008) 0.84
Killing of tumor cells: a drama in two acts. Biochem Pharmacol (2011) 0.84
Fluorescence properties of the Na⁺/H⁺exchanger inhibitor HMA (5-(N,N-hexamethylene)amiloride) are modulated by intracellular pH. Eur J Histochem (2012) 0.83
Study of the effects of a new pyrazolecarboxamide: changes in mitochondria and induction of apoptosis. Int J Biochem Cell Biol (2009) 0.82
Amiloride potentiates TRAIL-induced tumor cell apoptosis by intracellular acidification-dependent Akt inactivation. Biochem Biophys Res Commun (2005) 0.80
L-DNase II associated with active process during ethanol induced cell death in ARPE-19. Mol Vis (2004) 0.80
Leukocyte elastase inhibitor: a new regulator of PARP-1. Ann N Y Acad Sci (2009) 0.80
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res (2005) 11.52
Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans. Hum Mutat (2007) 3.93
Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms. Cancer Res (2007) 3.19
miR-205 Exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase Cepsilon. Cancer Res (2009) 2.52
Pazopanib in advanced and platinum-resistant urothelial cancer: an open-label, single group, phase 2 trial. Lancet Oncol (2012) 2.36
Candidate cell and matrix interaction domains on the collagen fibril, the predominant protein of vertebrates. J Biol Chem (2008) 1.92
Constitutive activation of PKA catalytic subunit in adrenal Cushing's syndrome. N Engl J Med (2014) 1.89
XX males SRY negative: a confirmed cause of infertility. J Med Genet (2011) 1.75
Rational design of shepherdin, a novel anticancer agent. Cancer Cell (2005) 1.74
Breast cancer stem cells: an overview. Eur J Cancer (2006) 1.61
miR-21: an oncomir on strike in prostate cancer. Mol Cancer (2010) 1.54
Feasibility and safety of adoptive immunotherapy with ex vivo-generated autologous, cytotoxic T lymphocytes in patients with solid tumor. Cytotherapy (2011) 1.54
Targeting survivin in cancer therapy: fulfilled promises and open questions. Carcinogenesis (2007) 1.50
Brittle IV mouse model for osteogenesis imperfecta IV demonstrates postpubertal adaptations to improve whole bone strength. J Bone Miner Res (2004) 1.47
Targeting survivin in cancer therapy. Expert Opin Ther Targets (2008) 1.47
Telomere maintenance mechanisms in liposarcomas: association with histologic subtypes and disease progression. Cancer Res (2006) 1.44
Survivin as a target for new anticancer interventions. J Cell Mol Med (2005) 1.37
Towards the definition of prostate cancer-related microRNAs: where are we now? Trends Mol Med (2009) 1.24
Conversation between apoptosis and autophagy: "Is it your turn or mine?". Apoptosis (2011) 1.24
Current and emerging treatments for the management of osteogenesis imperfecta. Ther Clin Risk Manag (2010) 1.21
New arylthioindoles and related bioisosteres at the sulfur bridging group. 4. Synthesis, tubulin polymerization, cell growth inhibition, and molecular modeling studies. J Med Chem (2009) 1.14
Anthocyanins induce cell cycle perturbations and apoptosis in different human cell lines. Carcinogenesis (2004) 1.14
Evaluation of a novel biomaterial in the suprachoroidal space of the rabbit eye. Invest Ophthalmol Vis Sci (2002) 1.13
Cellular mechanism of decreased bone in Brtl mouse model of OI: imbalance of decreased osteoblast function and increased osteoclasts and their precursors. J Bone Miner Res (2008) 1.12
Ribozyme-mediated attenuation of survivin expression sensitizes human melanoma cells to cisplatin-induced apoptosis. J Clin Invest (2002) 1.12
Dimerizable redox-sensitive triazine-based cationic lipids for in vitro gene delivery. ChemMedChem (2007) 1.12
The 6-year attendance of a multidisciplinary prostate cancer clinic in Italy: incidence of management changes. BJU Int (2012) 1.11
Generation of mesenchymal stromal cells in the presence of platelet lysate: a phenotypic and functional comparison of umbilical cord blood- and bone marrow-derived progenitors. Haematologica (2009) 1.10
p16(INK4A) Hypermethylation detected by fluorescent methylation-specific PCR in plasmas from non-small cell lung cancer. Clin Cancer Res (2002) 1.07
MicroRNAs as new therapeutic targets and tools in cancer. Expert Opin Ther Targets (2011) 1.07
Pathophysiology and biology of peritoneal carcinomatosis. World J Gastrointest Oncol (2010) 1.07
Characterization of novel antisense HIF-1α transcripts in human cancers. Cell Cycle (2011) 1.06
DNA ligase I deficiency leads to replication-dependent DNA damage and impacts cell morphology without blocking cell cycle progression. Mol Cell Biol (2009) 1.04
Arylthioindole inhibitors of tubulin polymerization. 3. Biological evaluation, structure-activity relationships and molecular modeling studies. J Med Chem (2007) 1.04
Small-molecule targeting of heat shock protein 90 chaperone function: rational identification of a new anticancer lead. J Med Chem (2006) 1.03
Glucocorticoids induce retinal toxicity through mechanisms mainly associated with paraptosis. Mol Vis (2007) 1.02
Loss of retinoblastoma tumor suppressor protein makes human breast cancer cells more sensitive to antimetabolite exposure. Clin Cancer Res (2008) 1.02
Multiple mechanisms of telomere maintenance exist and differentially affect clinical outcome in diffuse malignant peritoneal mesothelioma. Clin Cancer Res (2008) 1.02
G-quadruplex structures in the human genome as novel therapeutic targets. Molecules (2013) 1.02
Characterization of an inducible promoter in different DNA copy number conditions. BMC Bioinformatics (2012) 1.01
Impaired osteoblastogenesis in a murine model of dominant osteogenesis imperfecta: a new target for osteogenesis imperfecta pharmacological therapy. Stem Cells (2012) 1.00
TLR9 agonists oppositely modulate DNA repair genes in tumor versus immune cells and enhance chemotherapy effects. Cancer Res (2011) 1.00
Radiosensitization of human melanoma cells by ribozyme-mediated inhibition of survivin expression. J Invest Dermatol (2003) 1.00
XPO1/CRM1-selective inhibitors of nuclear export (SINE) reduce tumor spreading and improve overall survival in preclinical models of prostate cancer (PCa). J Hematol Oncol (2014) 0.99
Ribozyme-mediated inhibition of survivin expression increases spontaneous and drug-induced apoptosis and decreases the tumorigenic potential of human prostate cancer cells. Oncogene (2004) 0.99
Antisense oligonucleotide-mediated inhibition of hTERT, but not hTERC, induces rapid cell growth decline and apoptosis in the absence of telomere shortening in human prostate cancer cells. Eur J Cancer (2005) 0.98
Survivin is highly expressed and promotes cell survival in malignant peritoneal mesothelioma. Cell Oncol (2007) 0.98
Glycosaminoglycans show a specific periodic interaction with type I collagen fibrils. J Struct Biol (2008) 0.98
Potentiation of paclitaxel-induced apoptosis by the novel cyclin-dependent kinase inhibitor NU6140: a possible role for survivin down-regulation. Mol Cancer Ther (2005) 0.97
Rearrangement of nuclear ribonucleoprotein (RNP)-containing structures during apoptosis and transcriptional arrest. Biol Cell (2004) 0.97
Selective inhibition of rRNA transcription downregulates E2F-1: a new p53-independent mechanism linking cell growth to cell proliferation. J Cell Sci (2011) 0.97
Prognostic relevance of ALT-associated markers in liposarcoma: a comparative analysis. BMC Cancer (2010) 0.96
Evidence for alternative lengthening of telomeres in liposarcomas in the absence of ALT-associated PML bodies. Int J Cancer (2008) 0.96
Silencing of survivin gene by small interfering RNAs produces supra-additive growth suppression in combination with 17-allylamino-17-demethoxygeldanamycin in human prostate cancer cells. Mol Cancer Ther (2006) 0.96
HEM dysplasia and ichthyosis are likely laminopathies and not due to 3beta-hydroxysterol Delta14-reductase deficiency. Hum Mol Genet (2007) 0.95
Silencing of cellular prion protein (PrPC) expression by DNA-antisense oligonucleotides induces autophagy-dependent cell death in glioma cells. Autophagy (2011) 0.95
Acid DNases and their interest among apoptotic endonucleases. Biochimie (2006) 0.94
Synthesis and antitumor activity of 3-(2-phenyl-1,3-thiazol-4-yl)-1H-indoles and 3-(2-phenyl-1,3-thiazol-4-yl)-1H-7-azaindoles. ChemMedChem (2011) 0.93
miR-205 hinders the malignant interplay between prostate cancer cells and associated fibroblasts. Antioxid Redox Signal (2013) 0.92
Defective proteoglycan sulfation of the growth plate zones causes reduced chondrocyte proliferation via an altered Indian hedgehog signalling. Matrix Biol (2010) 0.92
Hybrid ligand-alkylating agents targeting telomeric G-quadruplex structures. Org Biomol Chem (2012) 0.92
Redox-active polymer microcapsules for the delivery of a survivin-specific siRNA in prostate cancer cells. ACS Nano (2011) 0.92
Emerging role of microRNAs in prostate cancer: implications for personalized medicine. Discov Med (2010) 0.91
Photochemical internalization: a new tool for drug delivery. Curr Pharm Biotechnol (2007) 0.91
A new indole-3-carbinol tetrameric derivative inhibits cyclin-dependent kinase 6 expression, and induces G1 cell cycle arrest in both estrogen-dependent and estrogen-independent breast cancer cell lines. Cancer Res (2003) 0.91
TCEAL7 inhibition of c-Myc activity in alternative lengthening of telomeres regulates hTERT expression. Neoplasia (2010) 0.90
Role of Apollon in human melanoma resistance to antitumor agents that activate the intrinsic or the extrinsic apoptosis pathways. Clin Cancer Res (2012) 0.90
Controlled delivery of 5-chlorouracil using poly(ortho esters) in filtering surgery for glaucoma. Invest Ophthalmol Vis Sci (2008) 0.90
The curative efficacy of namitecan (ST1968) in preclinical models of pediatric sarcoma is associated with antiangiogenic effects. Biochem Pharmacol (2012) 0.90
Ubiquitin over-expression promotes E6AP autodegradation and reactivation of the p53/MDM2 pathway in HeLa cells. Mol Cell Biochem (2008) 0.90
Telomeres as targets for anticancer therapies. Expert Opin Ther Targets (2011) 0.89
Structure, stability and interactions of type I collagen with GLY349-CYS substitution in alpha 1(I) chain in a murine Osteogenesis Imperfecta model. Matrix Biol (2004) 0.89
Ultrasonic and electromagnetic enhancement of a culture of human SAOS-2 osteoblasts seeded onto a titanium plasma-spray surface. Tissue Eng Part C Methods (2009) 0.89
Further delineation of CANT1 phenotypic spectrum and demonstration of its role in proteoglycan synthesis. Hum Mutat (2012) 0.89
Novel 1H-pyrrolo[2,3-b]pyridine derivative nortopsentin analogues: synthesis and antitumor activity in peritoneal mesothelioma experimental models. J Med Chem (2013) 0.89
Role of tyrosyl-DNA phosphodiesterase 1 and inter-players in regulation of tumor cell sensitivity to topoisomerase I inhibition. Biochem Pharmacol (2011) 0.89
Role of proliferation in HER2 status predicted response to doxorubicin. Int J Cancer (2003) 0.89
Modulation of sensitivity to antitumor agents by targeting the MAPK survival pathway. Curr Pharm Des (2013) 0.88
Targeting the Akt kinase to modulate survival, invasiveness and drug resistance of cancer cells. Curr Med Chem (2013) 0.88
Characterization of a new PEPD allele causing prolidase deficiency in two unrelated patients: natural-occurrent mutations as a tool to investigate structure-function relationship. J Hum Genet (2004) 0.88
Multiple apoptotic pathways induced by p53-dependent acidification in benzo[a]pyrene-exposed hepatic F258 cells. J Cell Physiol (2006) 0.87
Modified expression of Bcl-2 and SOD1 proteins in lymphocytes from sporadic ALS patients. Neurosci Lett (2006) 0.87
Induction of endoplasmic reticulum stress response by the indole-3-carbinol cyclic tetrameric derivative CTet in human breast cancer cell lines. PLoS One (2012) 0.87
Calpain 1 induce lysosomal permeabilization by cleavage of lysosomal associated membrane protein 2. Biochim Biophys Acta (2013) 0.87
Down-regulation of human telomerase reverse transcriptase through specific activation of RNAi pathway quickly results in cancer cell growth impairment. Biochem Pharmacol (2007) 0.87
Targeting the telosome: therapeutic implications. Biochim Biophys Acta (2009) 0.86